http://media.peerviewpress.com/000136/podcast/pvi/xml/aids_video.xml Tue, 03 Nov 2009 15:18:47 -0500 PVI, PeerView Institute for Medical Education http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2007 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/aidsvideo/vidAIDS-HIVCME-CNE-CPE_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV no PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in HIV discuss the most recent practice-changing developments in managing HIV, such as novel combinations of agents and management of non–HIV-related complications. http://podcast.peerviewpress.com/aidsvideo/PA05394FCr69.mp3 http://podcast.peerviewpress.com/aidsvideo/PA05394FCr69.m4v Thu, 15 Oct 2009 15:33:12 -0400 Science, Medicine no 00:30:36 HIV, HIV infection, HIV treatment PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA05394FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA05394FCCMEinfo.pdf Thu, 15 Oct 2009 15:33:10 -0400 Science, Medicine no 00:00:00 HIV, HIV infection, HIV treatment PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in the management of HIV discuss the clinical implications of recent developments for treatment-experienced patients. http://podcast.peerviewpress.com/aidsvideo/PPVNE05389r452.m4v http://podcast.peerviewpress.com/aidsvideo/PPVNE05389r452.m4v Tue, 30 Jun 2009 11:04:21 -0400 Science, Medicine no 00:26:33 HIV, ART, antiretroviral, PI, protease inhibitor, NNRTI, virologic suppression, treatment-experienced PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PPVNE05389CMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PPVNE05389CMEinfo.pdf Tue, 30 Jun 2009 11:04:13 -0400 Science, Medicine no 00:00:00 HIV, ART, antiretroviral, PI, protease inhibitor, NNRTI, virologic suppression, treatment-experienced PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, two leading experts in the area of HIV management will analyze the latest treatment guidelines for managing metabolic and cardiovascular risk in patients with HIV. Topics in these discussions include cardiovascular and metabolic considerations for individualizing therapy, treatment selection, and insight regarding switching therapies. In addition, practical considerations for the screening, monitoring, and management of these comorbidities in patients with HIV will be discussed. http://podcast.peerviewpress.com/aidsvideo/PA04256FCr431.m4v http://podcast.peerviewpress.com/aidsvideo/PA04256FCr431.m4v Tue, 24 Mar 2009 14:42:21 -0400 Science, Medicine no 00:32:04 HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04256FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04256FCCMEinfo.pdf Tue, 24 Mar 2009 14:42:18 -0400 Science, Medicine no 00:00:00 HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this case-based activity, an expert in HIV management discusses first-line treatment considerations in a young African American woman with 3 children, and therapeutic options for a treatment-experienced Hispanic man with HIV. http://podcast.peerviewpress.com/aidsvideo/PA04429FCp152.m4v http://podcast.peerviewpress.com/aidsvideo/PA04429FCp152.m4v Wed, 25 Feb 2009 16:29:18 -0500 Science, Medicine no 00:41:55 HIV, NNRTI, anitretrviral therapy, adherence, pill burden, viral load, CD4+ cell count, efavirenz, nevirapine PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04429FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04429FCCMEinfo.pdf Wed, 25 Feb 2009 16:28:33 -0500 Science, Medicine no 00:00:00 HIV, NNRTI, anitretrviral therapy, adherence, pill burden, viral load, CD4+ cell count, efavirenz, nevirapine PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in HIV management discuss the latest data and guidelines for effectively simplifying HIV therapy. http://podcast.peerviewpress.com/aidsvideo/PA05061FCr427.m4v http://podcast.peerviewpress.com/aidsvideo/PA05061FCr427.m4v Mon, 19 Jan 2009 15:03:12 -0500 Science, Medicine no 00:28:22 HIV, simplified regimens, antiretroviral therapy, virologic failure, ICAAC/IDSA, tenofovir, emtricitabine, efavirenz, raltegravir, NNRTI PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA05061FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA05061FCCMEinfo.pdf Mon, 19 Jan 2009 15:02:40 -0500 Science, Medicine no 00:00:00 HIV, simplified regimens, antiretroviral therapy, virologic failure, ICAAC/IDSA, tenofovir, emtricitabine, efavirenz, raltegravir, NNRTI PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. The first presentation reviews the latest data on entry inhibitors that target CCR5-tropic HIV, specifically from the recent ICAAC/IDSA conference. This discussion focuses on how these data can be applied to clinical practice, or not. The second presentation explores ongoing safety issues and concerns associated with entry inhibitors, focusing on long-term updates from clinical trials. The third and final presentation centers on the overall clinical approach to the treatment-experienced patient and entry inhibitors, including the use and interpretation of assays, drug interactions, appropriate patient selection. http://podcast.peerviewpress.com/aidsvideo/PA04879FCr437.m4v http://podcast.peerviewpress.com/aidsvideo/PA04879FCr437.m4v Wed, 24 Dec 2008 14:11:04 -0500 Science no 00:33:41 entry inhibitors, HIV, CD4, tropism, X4, R5, CXCR-4, ICAAC, IDSA, MERIT, MOTIVATE PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04879FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04879FCCMEinfo.pdf Wed, 24 Dec 2008 14:10:21 -0500 Science no 00:00:00 entry inhibitors, HIV, CD4, tropism, X4, R5, CXCR-4, ICAAC, IDSA, MERIT, MOTIVATE PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in HIV management discuss the latest data on simplified or fixed dose regimens, as well as strategies for simplifying initial and subsequent therapy. http://podcast.peerviewpress.com/aidsvideo/PA05060FCr417.m4v http://podcast.peerviewpress.com/aidsvideo/PA05060FCr417.m4v Wed, 03 Dec 2008 15:19:55 -0500 Science no 00:30:21 HIV, simplifying antiretroviral therapy, virologic suppression, fixed dose regimen, immunologic outcomes, adherence, protease inhibitors, NNRTIs PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA05060FCCMECEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA05060FCCMECEinfo.pdf Wed, 03 Dec 2008 15:14:55 -0500 Science no 00:00:00 HIV, simplifying antiretroviral therapy, virologic suppression, fixed dose regimen, immunologic outcomes, adherence, protease inhibitors, NNRTIs PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. The purpose of this panel-based educational activity is to provide a balanced, peer-to-peer perspective on some of the key issues facing HIV specialists, based on data presented at the XVII International AIDS Conference, August 3-8, 2008. http://podcast.peerviewpress.com/aidsvideo/PA04185FCe023.m4v http://podcast.peerviewpress.com/aidsvideo/PA04185FCe023.m4v Thu, 06 Nov 2008 13:05:08 -0500 Science, Medicine no 00:46:36 17th International AIDS Conference, AIDS 2008, HIV, NNRTI, viral load, protease inhibitor, abacavir, tenofovir PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04185FCe023CMECEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04185FCCMEinfo.pdf Thu, 06 Nov 2008 13:05:08 -0500 Science no 00:00:00 17th International AIDS Conference, AIDS 2008, HIV, NNRTI, viral load, protease inhibitor, abacavir, tenofovir PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. The non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an integral part of the success of antiretroviral therapy. Data continue to be published and presented at major medical conferences that provide updated information on the optimal use of current and emerging agents within this class for treatment-naïve as well as treatment-experienced patients. This program explores the clinical implications of these data. http://podcast.peerviewpress.com/aidsvideo/PA04428FCr416.m4v http://podcast.peerviewpress.com/aidsvideo/PA04428FCr416.m4v Thu, 30 Oct 2008 10:50:34 -0400 Science no 00:26:57 NNRTI, efavirenz, etravirine, emtricitabine, abacavir, lamivudine, SMART, DUET, raltegravir, rilpivirine, IDX899, RDEA806 PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04428FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04428FCCMEinfo.pdf Thu, 30 Oct 2008 10:50:27 -0400 Science no 00:00:00 NNRTI, efavirenz, etravirine, emtricitabine, abacavir, lamivudine, SMART, DUET, raltegravir, rilpivirine, IDX899, RDEA806 PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured. http://podcast.peerviewpress.com/aidsvideo/PA04255FCr403.m4v http://podcast.peerviewpress.com/aidsvideo/PA04255FCr403.m4v Thu, 31 Jul 2008 15:17:30 -0400 Science no 00:25:39 HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04255FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04255FCCMEinfo.pdf Thu, 31 Jul 2008 15:16:37 -0400 Science no 00:00:00 HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts evaluate recent data on the efficacy and safety of NNRTI-based regimens for treatment-naïve patients with HIV. An analysis of how patient-related and medication-related factors play a role in selecting initial NNRTI-based regimens is featured. http://podcast.peerviewpress.com/aidsvideo/PA04427FCr401.m4v http://podcast.peerviewpress.com/aidsvideo/PA04427FCr401.m4v Tue, 17 Jun 2008 11:14:17 -0400 Science no 00:20:41 AIDS, HIV, NNRTIs, DHHS, efavirenz, nevirapine, treatment-naïve, HAART PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04427FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04427FCCMEinfo.pdf Tue, 17 Jun 2008 11:11:45 -0400 Science no 00:00:00 AIDS, HIV, NNRTIs, DHHS, efavirenz, nevirapine, treatment-naïve, HAART PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV discuss recent issues on when to initiate antiretroviral agents and how and when to switch therapy. http://podcast.peerviewpress.com/aidsvideo/PA04259FCe019.m4v http://podcast.peerviewpress.com/aidsvideo/PA04259FCe019.m4v Fri, 30 May 2008 10:07:13 -0400 Science no 00:40:10 AIDS, HIV, treatment failure, virologic failure, immunologic failure, clinical progression, PI, NNRTI PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04259FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04259FCCMEinfo.pdf Fri, 30 May 2008 10:07:10 -0400 Science no 00:00:00 AIDS, HIV, treatment failure, virologic failure, immunologic failure, clinical progression, PI, NNRTI PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of a number of antiretroviral regimens used in the management of treatment-naïve patients. A discussion on the clinical implications of updated DHHS guidelines for the initiation of treatment is featured. http://podcast.peerviewpress.com/aidsvideo/PA04181FCs474.m4v http://podcast.peerviewpress.com/aidsvideo/PA04181FCs474.m4v Wed, 30 Apr 2008 14:40:48 -0400 Science no 00:30:08 AIDS, HIV, DHHS, CROI, lipoatrophy, SMART, CASTLE, M05-730, ACTG 5142 PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04181FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04181FCCMEinfo.pdf Wed, 30 Apr 2008 14:40:48 -0400 Science no 00:00:00 AIDS, HIV, DHHS, CROI, lipoatrophy, SMART, CASTLE, M05-730, ACTG 5142 PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new agents for the management of treatment-experienced patients with HIV. http://podcast.peerviewpress.com/aidsvideo/PA04547FCr381.m4v http://podcast.peerviewpress.com/aidsvideo/PA04547FCr381.m4v Thu, 17 Apr 2008 13:18:36 -0400 Science no 00:28:40 AIDS, HIV, CROI, raltegravir, maraviroc, etravirine, CCR5, DUET, BENCHMRK, MOTIVATE, tropism assay, treatment-experienced PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aidsvideo/PA04547FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04547FCCMEinfo.pdf Thu, 17 Apr 2008 13:18:33 -0400 Science no 00:00:00 AIDS, HIV, CROI, raltegravir, maraviroc, etravirine, CCR5, DUET, BENCHMRK, MOTIVATE, tropism assay, treatment-experienced PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the management of HIV review important issues to consider when individualizing antiretroviral therapy. The treatment of patients with HIV and comorbid HBV, HCV, or renal insufficiency, as well as management strategies for pregnant women are featured. http://podcast.peerviewpress.com/AIDSVideo/PA04154FCe011.m4v http://podcast.peerviewpress.com/aidsvideo/PA04154FCe011.m4v Tue, 08 Apr 2008 11:11:25 -0400 Science no 00:34:52 AIDS, HIV, DHHS, atazanavir, lopinavir, efavirenz, nevirapine, pregnancy, hepatitis, coinfection, zidovudine, lamivudine PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/AIDSVideo/PA04154FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04154FCCMEinfo.pdf Tue, 08 Apr 2008 11:10:22 -0400 Science no 00:00:00 AIDS, HIV, DHHS, atazanavir, lopinavir, efavirenz, nevirapine, pregnancy, hepatitis, coinfection, zidovudine, lamivudine PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present important issues regarding the management of HIV in women. The treatment of HIV in pregnant women is featured. http://podcast.peerviewpress.com/AIDSVideo/PA04268FCr389.m4v http://podcast.peerviewpress.com/aidsvideo/PA04268FCr389.m4v Fri, 28 Mar 2008 15:47:42 -0400 Science no 00:23:12 HIV, pregnancy, contraception, DHHS, efavirenz, nelfinavir, antitretrovirals, mother-to-child transmission, zidovudine PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/AIDSVideo/PA04268FCCMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04268FCCMEinfo.pdf Fri, 28 Mar 2008 15:47:41 -0400 Science no 00:00:00 HIV, pregnancy, contraception, DHHS, efavirenz, nelfinavir, antitretrovirals, mother-to-child transmission, zidovudine PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV assess the most recent updates to the DHHS guidelines on HIV management and discuss how these recommendations should be implemented into clinical practice. http://podcast.peerviewpress.com/AIDSVideo/PA03620FC3r360.m4v http://podcast.peerviewpress.com/aidsvideo/PA03620FC3CMEinfo.pdf Wed, 27 Feb 2008 12:37:20 -0500 Science no 00:00:00 AIDS, HIV, DHHS, guidelines,CD4 counts, abacavir, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, nelfinavir, fosamprenavir, resistance testing, genotype, haplotype, hepatitis B coinfection, pregnancy PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/AIDSVideo/PA03620FC3CMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA03620FC3r360.m4v Wed, 27 Feb 2008 12:37:20 -0500 Science no 00:15:50 AIDS, HIV, DHHS, guidelines,CD4 counts, abacavir, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, nelfinavir, fosamprenavir, resistance testing, genotype, haplotype, hepatitis B coinfection, pregnancy PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the treatment of HIV will examine key issues to consider when choosing an initial antiretroviral strategy. http://podcast.peerviewpress.com/AIDSVideo/PA03539FC2p130.m4v http://podcast.peerviewpress.com/aidsvideo/PA03539FC2p130.m4v Tue, 15 Jan 2008 13:40:31 -0500 Science no 00:52:16 AIDS, HIV, NNRTI, PI, zidovudine, lamivudine, tenofovir, emtricitabine, abacavir, efavirenz, nevirapine, atazanavir, lopinavir, fosamprenavir, darunavir, ritonavir, treatment-naïve, 2NN, DHHS, IAS-USA PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/AIDSVideo/PA03539FC2CMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA03539FC2CMEinfo.pdf Tue, 15 Jan 2008 13:39:31 -0500 Science no 00:00:00 AIDS, HIV, NNRTI, PI, zidovudine, lamivudine, tenofovir, emtricitabine, abacavir, efavirenz, nevirapine, atazanavir, lopinavir, fosamprenavir, darunavir, ritonavir, treatment-naïve, 2NN, DHHS, IAS-USA PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging antiretroviral agents. http://podcast.peerviewpress.com/AIDSVideo/PA04089FCs437.m4v http://podcast.peerviewpress.com/aidsvideo/PA04089FCs437.m4v Mon, 14 Jan 2008 09:20:02 -0500 Science no 00:34:34 AIDS, HIV, maraviroc, vicriviroc, raltegravir, elvitegravir, etravirine, TMC125, rilpivirine, TMC278, treatment experienced, CCR5, integrase inhibitors, ICAAC, IDSA, IAS, CXCR4, dual/mixed tropic, darunavir PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/AIDSVideo/PA04089FCCMECEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA04089FCCMEinfo.pdf Mon, 14 Jan 2008 09:20:01 -0500 Science no 00:00:00 AIDS, HIV, maraviroc, vicriviroc, raltegravir, elvitegravir, etravirine, TMC125, rilpivirine, TMC278, treatment experienced, CCR5, integrase inhibitors, ICAAC, IDSA, IAS, CXCR4, dual/mixed tropic, darunavir PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present current data on initial treatment options in HIV as well as efficacy and safety data on switching strategies. http://podcast.peerviewpress.com/AIDSVideo/PA03538FC3r429.m4v http://podcast.peerviewpress.com/aidsvideo/PA03538FC3s429.m4v Fri, 07 Dec 2007 15:45:57 -0500 Science no 00:20:36 AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, darunavir, maraviroc, raltegravir, stavudine, abacavir, integrase inhibitor, CD4, DHHS, IAS-USA, cholesterol, LDL, HDL PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/AIDSVideo/PA03538FC3CMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA03538FC3CMEinfo.pdf Fri, 07 Dec 2007 15:44:57 -0500 Science no 00:00:00 AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, darunavir, maraviroc, raltegravir, stavudine, abacavir, integrase inhibitor, CD4, DHHS, IAS-USA, cholesterol, LDL, HDL PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the treatment of HIV reviews initial treatment strategies in HIV and explores issues related to switching antiretroviral therapies. http://podcast.peerviewpress.com/AIDSVideo/PA03539FC1p122.m4v http://podcast.peerviewpress.com/aidsvideo/PA03539FC1p122.m4v Mon, 19 Nov 2007 16:29:58 -0500 Science no 00:55:22 AIDS, HIV, treatment-naïve, treatment experienced, zidovudine, lamivudine, abacavir, tenofovir, emtricitabine, atazanavir, fosamprenavir, lopinavir, darunavir, efavirenz, nevirapine, etravirine PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/AIDSVideo/PA03539FC1CMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA03539FC1CMEinfo.pdf Mon, 19 Nov 2007 16:29:57 -0500 Science no 00:00:00 AIDS, HIV, treatment-naïve, treatment experienced, zidovudine, lamivudine, abacavir, tenofovir, emtricitabine, atazanavir, fosamprenavir, lopinavir, darunavir, efavirenz, nevirapine, etravirine PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most recent recommendations for creating maximally suppressive antiretroviral regimens for treatment-experienced patients with HIV. http://podcast.peerviewpress.com/AIDSVideo/PA03620FC2r340.m4v http://podcast.peerviewpress.com/aidsvideo/PA03620FC2r340.m4v Thu, 01 Nov 2007 14:35:53 -0400 Science no 00:21:16 AIDS, HIV, DHHS, treatment-experienced, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, marviroc, raltegravir, fosamprenavir, resistance testing, genotype, phenotype PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/AIDSVideo/PA03620FC2CMEinfo.pdf http://podcast.peerviewpress.com/aidsvideo/PA03620FC2CMEinfo.pdf Thu, 01 Nov 2007 14:35:53 -0400 Science no 00:00:00 AIDS, HIV, DHHS, treatment-experienced, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, marviroc, raltegravir, fosamprenavir, resistance testing, genotype, phenotype